Premier Partners — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
MUSTBIOmustbio.comMar 2026 · $23.5M
Korean immuno-oncology biotech developing multi-specific antibody and immune-cytokine fusion therapies for cancer.
Co-investorsAtinum Investment Co. Ltd.Korea Development BankKorea Investment PartnersShinhan CapitalWONIK Investment Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.